Physician profile
Scott C Nelson
NPI 1366448649
$15,597.47
in general payments reported to CMS, 2019-2025
21 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $3,241 · 2021: $3,972 · 2022: $6,951 · 2023: $294 · 2024: $389 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008 · Travel and Lodging: $37.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.76 |
| Travel and Lodging | $37.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,064.52 | 2020-2022 | |
| Conetic Solutions, INC. | $5,558.16 | 2019-2025 | |
| Stryker Corporation | $547.94 | 2019-2025 | Viaflow, Variax, Augment Injectable |
| Depuy Synthes Sales INC. | $272.69 | 2019-2025 | Motoband |
| Zimmer Biomet Holdings, INC. | $254.53 | 2019-2024 | Rosa |
| Smith+Nephew, INC. | $167.03 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Stravix Pl, Renasys Go V2 Home |
| Kerecis Limited | $160.85 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Treace Medical Concepts, INC. | $145.31 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $115.81 | 2023 | |
| Biogennix, LLC | $85.97 | 2022 | |
| Sanara Medtech INC. | $42.59 | 2022-2024 | Celleraterx |
| Orthofix Medical, INC. | $29.20 | 2025 | Accelstim |
| Misonix INC | $26.65 | 2020 | |
| Spr Therapeutics, INC | $23.97 | 2022 | |
| Becton, Dickinson and Company | $18.11 | 2025 | Surgiphor |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $17.37 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mallinckrodt Enterprises LLC | $15.19 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.14 | 2024 | Nuzyra |
| Amgen INC. | $12.76 | 2022 | |
| Melinta Therapeutics, LLC | $12.47 | 2019 | |
| Ethicon US, LLC | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.